Revenue distribution by sectors:

1. Crop protection products: approx. 60%
2. Seeds and biotechnology: approx. 25%
3. Environmental sciences and others: approx. 15%

TOP 3 Markets:

1. India: approx. 40%
2. Brazil: approx. 25%
3. USA: approx. 15%

Bayer CropScience Limited generates the majority of its revenue from the crop protection products segment, which accounts for about 60% of total revenue. The Indian market is the largest single market for the company, contributing approximately 40% to total revenue. Brazil and the USA follow as important markets, together accounting for about 40% of revenue. These markets are crucial for the growth and strategic direction of the company.

Production Sites: India, Germany, USA

Bayer CropScience Limited produces its products at several locations worldwide. In India, the company operates significant production facilities, as the Indian market plays a central role in Bayer's agricultural strategy. In addition, Bayer CropScience has production sites in Germany and the USA, which are crucial for the manufacturing and development of crop protection products and seeds.

This geographical diversification enables Bayer to efficiently respond to regional market requirements and optimize supply chains.

Strategic Focus Points of Bayer CropScience Limited:

1. Research and Development: Bayer CropScience continuously invests in research and development to develop innovative solutions in the field of crop protection and seeds. This includes both chemical and biological products.

2. Digitization of Agriculture: The company is increasingly focusing on digital agricultural solutions to provide farmers with precise analysis tools and data-based decision support. This is intended to increase the efficiency and sustainability of agricultural production.

3. Sustainability and Climate Protection: Bayer CropScience aims to promote sustainable agricultural practices. This includes reducing the ecological footprint of their products and supporting farmers in adapting to climate change.

4. Market Expansion: The company plans to expand its presence in emerging markets to benefit from the increasing demand for agricultural solutions in these regions.

Through these strategic measures, Bayer CropScience aims to strengthen its market position and ensure long-term growth.

Main Imported Raw Materials: Pesticides, Seeds, Chemical Basics

Countries of Origin: USA, China, Germany

Bayer CropScience Limited imports a variety of raw materials needed for the production of pesticides and seeds. The most important imported materials include chemical basics and specific pesticides used in production.

The USA and Germany are significant suppliers, especially for high-quality chemical components and technologies. China plays a crucial role in supplying more cost-effective chemical basics. These imports are crucial for maintaining the production capacities and competitiveness of Bayer CropScience Limited in the global market.

Market share: 12% (estimated for 2026)
R&D investments: 1.2 billion euros (2025)
EBITDA margin: 18% (2025)

Bayer CropScience Limited has a significant competitive advantage due to its strong market position and extensive investments in research and development. With an estimated market share of 12% in 2026, the company remains a leading player in the agricultural sector. This position is supported by continuous innovations and a wide range of products.

The high R&D investments of 1.2 billion euros in 2025 demonstrate the company's commitment to developing new technologies and products that meet the evolving needs of agriculture. This enhances competitiveness and enables Bayer CropScience to stand out from competitors.

Furthermore, a solid EBITDA margin of 18% in 2025 contributes to financial stability, providing the company with flexibility for future investments and strategic initiatives. Bayer CropScience's competitive advantage is sustainably supported by these factors.

Institutional Investor Share: 45% (estimated for 2026)
Insider Purchases/Sales: No significant transactions reported (2026)

The institutional investor share in Bayer CropScience Limited is estimated to be around 45%. This estimate is based on historical trends and the company's overall market position.

In 2026, no significant insider purchases or sales were reported. This suggests that the management and insiders have confidence in the current company strategy and are not making any significant changes to their holdings.

Institutional investors play an important role in stock stability as they typically have a long-term outlook. The absence of significant insider transactions can be seen as a sign of stability and confidence in the company's future development.

Market share of Bayer CropScience Limited: Estimated 8% (2026)

Top competitors and their market shares:

1. Syngenta AG: 12%
2. Corteva Agriscience: 10%
3. BASF SE: 9%
4. Bayer CropScience Limited: 8%
5. FMC Corporation: 7%
6. ADAMA Agricultural Solutions: 6%
7. UPL Limited: 5%
8. Nufarm Limited: 4%
9. Sumitomo Chemical: 3%
10. KWS SAAT SE: 2%

Bayer CropScience Limited has a moderate market share in the global agrochemical sector. The market is highly fragmented, and competition is intense. Bayer CropScience's moat mainly lies in its strong research and development, wide product range, and global presence.

Compared to its competitors, Syngenta has a stronger moat, particularly due to its comprehensive solutions in crop protection and seeds. Corteva Agriscience benefits from a strong position in the seed market and innovative product development.

Bayer CropScience must continuously invest in innovations and strategic partnerships to maintain and strengthen its competitiveness. The competitive advantage could be further enhanced through technological advancements and a sustainable agricultural strategy.

Revenue Growth: 8.5% (2025) R&D Expenses: 12% of revenue (2025) Market Share in India: 25% (2025)

Bayer CropScience Limited achieved a revenue growth of 8.5% in 2025, driven by strong demand for their agricultural solutions and products. The company continues to invest significantly in research and development, with expenses accounting for 12% of revenue. These investments are crucial for developing innovative products and ensuring competitiveness.

Bayer CropScience's market share in India stands at approximately 25%, making the company one of the key players in this important growth market. This strong market position provides a solid foundation for future growth, especially in a country heavily reliant on agriculture.

Overall, the solid revenue growth, significant R&D investments, and strong market position support a positive long-term outlook for the stock. However, investors should also consider external factors such as regulatory changes and climatic conditions that can impact the agricultural industry.

Dividend Yield: 2.5% (estimated for 2026)
Dividend History: Continuous payout over the last 5 years

Bayer CropScience Limited has regularly distributed dividends to its shareholders in recent years. The company's dividend policy shows a tendency towards stability, indicating a reliable payout.

The estimated dividend yield of 2.5% for the year 2026 is based on historical payouts and the company's current financial performance. Bayer CropScience Limited has proven in the past that it is able to pay dividends even in economically challenging times, indicating a solid financial foundation and strategic planning.